Unlocking the Power of Genomics for Surveillance of SARS-CoV-2 Variants

Surveillance of SARS-Cov-2 mutations is essential to managing both on-going and future pandemics. Growing concerns over the recent fast-spreading, novel coronavirus variants highlights the need for increased sequencing to detect mutations quickly and prevent the spread of new strains. Next-generation sequencing (NGS) allows labs to: 

• Track virus transmission routes 
• Identify viral mutations that can avoid detection by established molecular diagnostic tests 
• Identify viral mutations that can evade the immune system as well as affect vaccine efficacy 
• Identify strains that may require public health action 
• Identify co-infections and antimicrobial resistance alleles 

In this seminar, we will cover the Illumina COVIDSeq Test (RUO) and additional methods for SARS-CoV-2 surveillance, including requirements, workflow, and analysis.

Presented by:

Kelly Hoon
Executive Sales Specialist
Microbiology and Infectious Diseases
Illumina